Esophageal Squamous Cell Carcinoma

About
Mappings

NCI Thesaurus: Esophageal Squamous Cell Carcinoma (coding:ncit:C4024)

OncoTree: Esophageal Squamous Cell Carcinoma (coding:oncotree:ESCC)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
EMA (2) PD-L1 >= 1% Esophageal Squamous Cell Carcinoma Ipilimumab, Nivolumab
EMA (1) PD-L1 >= 1% Esophageal Squamous Cell Carcinoma Cisplatin, Fluorouracil, Nivolumab
EMA (1) PD-L1 (TAP) >= 5% Esophageal Squamous Cell Carcinoma Cisplatin, Fluorouracil, Tislelizumab
EMA (1) PD-L1 (TAP) >= 5% Esophageal Squamous Cell Carcinoma Capecitabine, Cisplatin, Tislelizumab
EMA (1) PD-L1 (TAP) >= 5% Esophageal Squamous Cell Carcinoma Fluorouracil, Oxaliplatin, Tislelizumab
EMA (1) PD-L1 (TAP) >= 5% Esophageal Squamous Cell Carcinoma Capecitabine, Oxaliplatin, Tislelizumab
EMA (1) PD-L1 (TAP) >= 5% Esophageal Squamous Cell Carcinoma Cisplatin, Paclitaxel, Tislelizumab
EMA (1) PD-L1 (TAP) >= 5% Esophageal Squamous Cell Carcinoma Oxaliplatin, Paclitaxel, Tislelizumab
FDA (2) PD-L1 (TAP) >= 1% Esophageal Squamous Cell Carcinoma Cisplatin, Fluorouracil, Tislelizumab
FDA (2) PD-L1 (TAP) >= 1% Esophageal Squamous Cell Carcinoma Capecitabine, Cisplatin, Tislelizumab
FDA (2) PD-L1 (TAP) >= 1% Esophageal Squamous Cell Carcinoma Fluorouracil, Oxaliplatin, Tislelizumab
FDA (2) PD-L1 (TAP) >= 1% Esophageal Squamous Cell Carcinoma Capecitabine, Oxaliplatin, Tislelizumab
FDA (2) PD-L1 (TAP) >= 1% Esophageal Squamous Cell Carcinoma Cisplatin, Paclitaxel, Tislelizumab
FDA (2) PD-L1 (TAP) >= 1% Esophageal Squamous Cell Carcinoma Oxaliplatin, Paclitaxel, Tislelizumab
FDA (2) PD-L1 (CPS) >= 1 Esophageal Squamous Cell Carcinoma Cisplatin, Fluorouracil, Tislelizumab
FDA (2) PD-L1 (CPS) >= 1 Esophageal Squamous Cell Carcinoma Capecitabine, Cisplatin, Tislelizumab
FDA (2) PD-L1 (CPS) >= 1 Esophageal Squamous Cell Carcinoma Fluorouracil, Oxaliplatin, Tislelizumab
FDA (2) PD-L1 (CPS) >= 1 Esophageal Squamous Cell Carcinoma Capecitabine, Oxaliplatin, Tislelizumab
FDA (2) PD-L1 (CPS) >= 1 Esophageal Squamous Cell Carcinoma Cisplatin, Paclitaxel, Tislelizumab
FDA (2) PD-L1 (CPS) >= 1 Esophageal Squamous Cell Carcinoma Oxaliplatin, Paclitaxel, Tislelizumab